ad image

Non-Small Cell Lung Cancer

1 / 1
BeiGene
Clinical Trial

BeiGene Initiates New Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab Combined with Chemotherapy as First-line Treatment for Patients with Advanced Squamous Non-Small Cell Lung Cancer in China

BeiGene

PR-M08-18-NI-115Aug 30, 2018
Xcovery
Clinical Trials

Xcovery Announces First Cohort of Patients Dosed in a Phase 1/2 Clinical Trial of Vorolanib

Xcovery

PR-M08-18-NI-035Aug 09, 2018
1 / 1